This company listing is no longer active
Medivir Management
Management criteria checks 3/4
Key information
Jens Lindberg
Chief executive officer
SEK 3.4m
Total compensation
| CEO salary percentage | 65.77% |
| CEO tenure | 1.3yrs |
| CEO ownership | n/a |
| Management average tenure | 2.5yrs |
| Board average tenure | 5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2023 | n/a | n/a | -SEK 75m |
| Dec 31 2022 | SEK 3m | SEK 2m | -SEK 89m |
Compensation vs Market: Jens's total compensation ($USD331.60K) is below average for companies of similar size in the US market ($USD766.67K).
Compensation vs Earnings: Insufficient data to compare Jens's compensation with company performance.
CEO
Jens Lindberg (51 yo)
Mr. Jens Lindberg serves as Chief Executive Officer at Medivir AB (publ) since January 24, 2022. He served as Acting Chief Executive Officer at Sedana Medical AB (publ) since June 1, 2021 until 2021 and se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.3yrs | SEK 3.43m | no data | |
| Chief Financial Officer | 3.8yrs | SEK 2.66m | 0.038% $ 15.4k | |
| Chief Scientific Officer & Chief Medical Officer | 3.7yrs | no data | 0.12% $ 50.8k | |
| Chief Medical Officer | less than a year | no data | no data | |
| Senior Principal Scientist & MIV-818 Project Leader | no data | no data | no data |
Experienced Management: MVRB.F's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 5yrs | SEK 260.00k | 0.036% $ 14.7k | |
| Chairman of the Board | 5yrs | SEK 690.00k | 0.54% $ 220.1k | |
| Director | 2yrs | SEK 260.00k | 0.045% $ 18.3k | |
| Independent Director | 6yrs | SEK 260.00k | 0.029% $ 11.7k | |
| Independent Director | 1yr | SEK 260.00k | no data |
Experienced Board: MVRB.F's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/05/01 00:33 |
| End of Day Share Price | 2023/02/01 00:00 |
| Earnings | 2023/03/31 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medivir AB (publ) is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Mattias Häggblom | Danske Bank |
| Klas Palin | DNB Carnegie Commissioned Research |